The National Institutes of Biomedical Innovation, Health and Nutrition in partnership with Shionogi & Co. has successfully identified a novel antiviral antibody for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), its variants, and closely associated coronavirus species.
February 16, 2022
· 1 min read